Skip to main content
OpenTrials
Completed

NCT Number: NCT06997445

Jacobson's Progressive Muscle Relaxation Technique With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive Individuals

The study is a randomized controlled trial. The purpose of study is to compare the additive effects of Jacobson's progressive muscle relaxation technique with aerobic exercise versus aerobic exercise on cardiopulmonary parameters including systolic and diastolic blood pressure, heart rate, respiratory rate, rate pressure product and quality of life in stage 1 hypertensive individuals.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Foundation University College of Physical Therapy, Islamabad, 44000

Islamabad, 44000, Pakistan

About this study

The study will consist of referred stage 1 hypertensive patients by medical specialist/cardiologist.

Participants will be screened through PAR-Q and IPAQ Questionnaire. Cardiac monitor will be used for assessing the cardiopulmonary parameters. SF-36 Questionnaire will be used for assessing the quality of life. Informed written consent will be taken after which participants will be recruited into two groups.

Control group will be provided aerobic exercise while interventional group will be provided Jacobson's progressive muscle relaxation technique with aerobic exercise.

Outcome measures assessment will be done at pre-session, at 2 weeks and after 4 weeks post-intervention

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults: aged (18-45 years)
  • Gender: both male and female
  • Patients diagnosed with stage 1 hypertension (130-139 / 80-89 mmHg according to AHA/ACC 2017 guidelines
  • Mild to moderate physical activity level on IPAQ Questionnaire
  • Individuals who are able to understand and follow the instructions for exercise

Exclusion criteria

  • Unstable angina, MI, heart failure, advanced CAD patients
  • Severe neurological, musculoskeletal, or gynaecological conditions which limit participation in study
  • Recent history of fracture
  • Morbidly obese (BMI > 40.0 kg / m2)

Treatment and study plan

Interventional group: Jacobson's progressive muscle relaxation technique with aerobic exercise

Other

Jacobaon's progressive muscle relaxation technique for 15 minutes Total duration: 45 minutes

Aerobic Exercise

Other

Participants in this group will only be provided aerobic exercise for 4 weeks supervised by physiotherapist.

Aerobic Exercise include the following:

  • Warm up exercises for 5 minutes.
  • Brisk walking on treadmill for 25 minutes which include warm up period for 10 minutes then 14 minutes brisk walk and cool down period included 1 minute walk.
  • Stepper for 5 minutes.
  • Static cycling for 5 minutes.
  • Cool down for 5 minutes.

Week 03 and Week 04:

Frequency: 5 days per week Intensity: 60-80% Target heart rate Time: 45 minutes

Week 01 and Week 02:

Frequency: 5 days per week Intensity: 50-60 % Target heart rate Time: 45 minutes

Primary outcomes

  1. Systolic and diastolic blood pressure

    Time frame: 04 Weeks

    Evaluation will be done using cardiac monitor for blood pressure.

  2. Heart rate

    Time frame: 04 Weeks

    It will be measured through pulse oximeter.

  3. Respiratory rate

    Time frame: 04 Weeks

    It will be measured by counting the number of breaths a person takes per minute

  4. Rate pressure product

    Time frame: 04 Weeks

    It will be calculated by multiplying heart rate with systolic blood pressure

Sponsors and collaborators

Lead sponsor

Foundation University Islamabad

Other

Registry information

Official study title

Additive Effects of Jacobson's Progressive Muscle Relaxation Technique With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive Individuals

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
May 30, 2025
Registry last updated
Sep 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.